vs
Encompass Health Corp（EHC）とWorthington Steel, Inc.（WS）の財務データ比較。上の社名をクリックして会社を切り替えられます
Encompass Health Corpの直近四半期売上が大きい（$1.5B vs $871.9M、Worthington Steel, Inc.の約1.8倍）。Encompass Health Corpの純利益率が高く（9.5% vs 2.2%、差は7.3%）。Worthington Steel, Inc.の前年同期比売上増加率が高い（18.0% vs 9.9%）。Encompass Health Corpの直近四半期フリーキャッシュフローが多い（$116.7M vs $74.6M）。過去8四半期でEncompass Health Corpの売上複合成長率が高い（8.3% vs 3.9%）
エンコンパスヘルスコーポレーション（旧Amcare、HealthSouth）は米国アラバマ州バーミンガムに本社を置く米国最大の入院リハビリサービス事業者で、39州とプエルトリコに173の入院リハビリ病院を展開し、脳卒中や神経疾患、心肺疾患、脳損傷から回復中の患者に専門的な治療とケアを提供している。
ワージントンスチールは米国オハイオ州コロンバスに本社を置く工業製造企業で、消費者向け製品と建築向け製品の2つの事業セグメントを展開している。プロパン、酸素、ヘリウムタンクをはじめ、冷媒用・産業用ガスボンベ、キャンプ用・民生用ボンベ、さらに貯蔵・処理・加熱・膨張・流量制御に用いる水系タンクなど、多種多様な圧力容器の設計・製造を手がけている。
EHC vs WS — 直接比較
損益計算書 — Q4 FY2025 vs Q2 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $1.5B | $871.9M |
| 純利益 | $146.1M | $18.8M |
| 粗利率 | — | 10.7% |
| 営業利益率 | 16.7% | 2.5% |
| 純利益率 | 9.5% | 2.2% |
| 売上前年比 | 9.9% | 18.0% |
| 純利益前年比 | 20.8% | 46.9% |
| EPS（希薄化後） | $1.43 | $0.37 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $1.5B | $871.9M | ||
| Q3 25 | $1.5B | $872.9M | ||
| Q2 25 | $1.5B | $832.9M | ||
| Q1 25 | $1.5B | $687.4M | ||
| Q4 24 | $1.4B | $739.0M | ||
| Q3 24 | $1.4B | $834.0M | ||
| Q2 24 | $1.3B | — | ||
| Q1 24 | $1.3B | $805.8M |
| Q4 25 | $146.1M | $18.8M | ||
| Q3 25 | $126.5M | $36.8M | ||
| Q2 25 | $142.1M | $55.7M | ||
| Q1 25 | $151.5M | $13.8M | ||
| Q4 24 | $120.9M | $12.8M | ||
| Q3 24 | $108.2M | $28.4M | ||
| Q2 24 | $114.1M | — | ||
| Q1 24 | $112.5M | $49.0M |
| Q4 25 | — | 10.7% | ||
| Q3 25 | — | 13.2% | ||
| Q2 25 | — | 15.2% | ||
| Q1 25 | — | 11.8% | ||
| Q4 24 | — | 10.8% | ||
| Q3 24 | — | 12.0% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 14.9% |
| Q4 25 | 16.7% | 2.5% | ||
| Q3 25 | 14.9% | 5.5% | ||
| Q2 25 | 16.2% | 8.0% | ||
| Q1 25 | 16.4% | 2.7% | ||
| Q4 24 | 14.3% | 2.6% | ||
| Q3 24 | 13.6% | 5.2% | ||
| Q2 24 | 14.3% | — | ||
| Q1 24 | 13.6% | 8.2% |
| Q4 25 | 9.5% | 2.2% | ||
| Q3 25 | 8.6% | 4.2% | ||
| Q2 25 | 9.7% | 6.7% | ||
| Q1 25 | 10.4% | 2.0% | ||
| Q4 24 | 8.6% | 1.7% | ||
| Q3 24 | 8.0% | 3.4% | ||
| Q2 24 | 8.8% | — | ||
| Q1 24 | 8.5% | 6.1% |
| Q4 25 | $1.43 | $0.37 | ||
| Q3 25 | $1.24 | $0.72 | ||
| Q2 25 | $1.39 | $1.11 | ||
| Q1 25 | $1.48 | $0.27 | ||
| Q4 24 | $1.18 | $0.25 | ||
| Q3 24 | $1.06 | $0.56 | ||
| Q2 24 | $1.12 | — | ||
| Q1 24 | $1.10 | $0.98 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $72.2M | $89.8M |
| 総負債低いほど良い | $2.4B | $72.1M |
| 株主資本純資産 | $2.4B | $1.1B |
| 総資産 | $7.1B | $2.1B |
| 負債/資本比率低いほどレバレッジが低い | 1.00× | 0.06× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $72.2M | $89.8M | ||
| Q3 25 | $48.7M | $78.3M | ||
| Q2 25 | $99.1M | $38.0M | ||
| Q1 25 | $95.8M | $63.3M | ||
| Q4 24 | $85.4M | $52.0M | ||
| Q3 24 | $147.8M | $36.0M | ||
| Q2 24 | $154.4M | — | ||
| Q1 24 | $134.4M | $60.8M |
| Q4 25 | $2.4B | $72.1M | ||
| Q3 25 | $2.4B | $73.4M | ||
| Q2 25 | $2.3B | $151.5M | ||
| Q1 25 | $2.3B | — | ||
| Q4 24 | $2.4B | $115.0M | ||
| Q3 24 | $2.3B | $122.2M | ||
| Q2 24 | $2.7B | — | ||
| Q1 24 | $2.7B | $147.2M |
| Q4 25 | $2.4B | $1.1B | ||
| Q3 25 | $2.4B | $1.1B | ||
| Q2 25 | $2.3B | $1.1B | ||
| Q1 25 | $2.2B | $1.0B | ||
| Q4 24 | $2.1B | $1.0B | ||
| Q3 24 | $2.0B | $1.0B | ||
| Q2 24 | $1.8B | — | ||
| Q1 24 | $1.7B | $937.6M |
| Q4 25 | $7.1B | $2.1B | ||
| Q3 25 | $6.9B | $2.2B | ||
| Q2 25 | $6.8B | $2.0B | ||
| Q1 25 | $6.6B | $1.8B | ||
| Q4 24 | $6.5B | $1.7B | ||
| Q3 24 | $6.5B | $1.8B | ||
| Q2 24 | $6.4B | — | ||
| Q1 24 | $6.2B | $1.8B |
| Q4 25 | 1.00× | 0.06× | ||
| Q3 25 | 1.01× | 0.07× | ||
| Q2 25 | 1.02× | 0.14× | ||
| Q1 25 | 1.08× | — | ||
| Q4 24 | 1.14× | 0.11× | ||
| Q3 24 | 1.20× | 0.12× | ||
| Q2 24 | 1.46× | — | ||
| Q1 24 | 1.54× | 0.16× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $346.0M | $99.3M |
| フリーキャッシュフロー営業CF - 設備投資 | $116.7M | $74.6M |
| FCFマージンFCF / 売上 | 7.6% | 8.6% |
| 設備投資強度設備投資 / 売上 | 14.8% | 2.8% |
| キャッシュ転換率営業CF / 純利益 | 2.37× | 5.28× |
| 直近12ヶ月FCF直近4四半期 | $439.2M | $72.5M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $346.0M | $99.3M | ||
| Q3 25 | $270.8M | $-6.3M | ||
| Q2 25 | $270.2M | $53.9M | ||
| Q1 25 | $288.6M | $53.8M | ||
| Q4 24 | $278.8M | $68.0M | ||
| Q3 24 | $267.8M | $54.6M | ||
| Q2 24 | $217.4M | — | ||
| Q1 24 | $238.8M | $44.7M |
| Q4 25 | $116.7M | $74.6M | ||
| Q3 25 | $83.7M | $-35.7M | ||
| Q2 25 | $113.3M | $8.4M | ||
| Q1 25 | $125.5M | $25.2M | ||
| Q4 24 | $80.1M | $33.2M | ||
| Q3 24 | $120.3M | $33.1M | ||
| Q2 24 | $60.5M | — | ||
| Q1 24 | $99.4M | $22.3M |
| Q4 25 | 7.6% | 8.6% | ||
| Q3 25 | 5.7% | -4.1% | ||
| Q2 25 | 7.8% | 1.0% | ||
| Q1 25 | 8.6% | 3.7% | ||
| Q4 24 | 5.7% | 4.5% | ||
| Q3 24 | 8.9% | 4.0% | ||
| Q2 24 | 4.6% | — | ||
| Q1 24 | 7.6% | 2.8% |
| Q4 25 | 14.8% | 2.8% | ||
| Q3 25 | 12.7% | 3.4% | ||
| Q2 25 | 10.8% | 5.5% | ||
| Q1 25 | 11.2% | 4.2% | ||
| Q4 24 | 14.1% | 4.7% | ||
| Q3 24 | 10.9% | 2.6% | ||
| Q2 24 | 12.1% | — | ||
| Q1 24 | 10.6% | 2.8% |
| Q4 25 | 2.37× | 5.28× | ||
| Q3 25 | 2.14× | -0.17× | ||
| Q2 25 | 1.90× | 0.97× | ||
| Q1 25 | 1.90× | 3.90× | ||
| Q4 24 | 2.31× | 5.31× | ||
| Q3 24 | 2.48× | 1.92× | ||
| Q2 24 | 1.91× | — | ||
| Q1 24 | 2.12× | 0.91× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
WS
| Direct | $844.1M | 97% |
| Toll | $27.8M | 3% |
